Covid Trial Articles & Analysis: Older
6 articles found
With zapnometinib’s favorable outcome in a recent phase II clinical trial in hospitalized COVID-19 patients, the present results are even more promising for an upcoming phase II clinical trial in severe influenza virus infection. 1 Introduction As of today, virus infections, especially those with pandemic potential, still pose a major ...
With the emergence of COVID-19, Decentralisation of Clinical Trials became necessary to comply with social distancing requirements while carrying out clinical research. Over the past few years, the clinical trial landscape has shifted its focus to patient-centric practices to promote patient engagement. ...
ByClinion
Mic qpcr cycler and Myra liquid handler have been put through their paces in COVID-19-testing field trials in regional Western Australia and found to be noticeably robust, rapidly deployable and flexible. ...
Covid-19 is approaching its one-year mark in the United States. As cases are on the rise again, people all over the world are eager for a cure. In the past few days, Moderna and Pfizer have released some promising clinical trials of their Covid-19 vaccinations. While these are still in the trial phase, many remain hopeful ...
As Covid-19 counts continue to rise in North America, Europe and throughout the world, the potential for a vaccine comes at a critical time as scientists seek to prevent transmission of the virus by individuals already infected. On November 9, 2020, Pfizer and BioNTech announced that their trial of a Covid-19 vaccine showed a 90% efficacy ...
Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation that accompanies severe cases of COVID-19. ...